MARKET

MENS

MENS

Jyong Biotech Ltd.
NASDAQ
1.680
-0.060
-3.45%
Closed 16:10 11/12 EST
OPEN
1.720
PREV CLOSE
1.740
HIGH
1.810
LOW
1.680
VOLUME
20.10K
TURNOVER
--
52 WEEK HIGH
41.20
52 WEEK LOW
1.430
MARKET CAP
127.73M
P/E (TTM)
-26.2500
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MENS last week (1102-1106)?
Weekly Report · 4d ago
Weekly Report: what happened at MENS last week (1026-1030)?
Weekly Report · 11/02 09:04
Weekly Report: what happened at MENS last week (1019-1023)?
Weekly Report · 10/26 09:04
Weekly Report: what happened at MENS last week (1012-1016)?
Weekly Report · 10/19 09:04
Jyong Biotech Plans Potential Texas Manufacturing Facility And U.S. Operations Center To Support Future Commercialization Of Drug Candidates
Benzinga · 10/15 13:11
Weekly Report: what happened at MENS last week (1005-1009)?
Weekly Report · 10/12 09:04
Weekly Report: what happened at MENS last week (0928-1002)?
Weekly Report · 10/05 09:05
Weekly Report: what happened at MENS last week (0921-0925)?
Weekly Report · 09/28 09:04
More
About MENS
Jyong Biotech Ltd is a Taiwan-based science-driven biotechnology company. The Company is mainly engaged in developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the United States (U.S.), the European Union (EU), and Asia. The Company has been developing a series of botanical drug candidates, including primary botanical drug candidate of MCS-2, another clinical-stage botanical drug candidate of PCP, and other preclinical-stage botanical drug candidates. MCS-2 is a new botanical drug candidate developed for treatment of benign prostate hyperplasia/lower urinary tract symptoms (BPH/LUTS). PCP is a new botanical drug candidate developed for the prevention of prostate cancer.

Webull offers Jyong Biotech Ltd. stock information, including NASDAQ: MENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MENS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MENS stock methods without spending real money on the virtual paper trading platform.